By Sarah Calkin2016-04-21T09:52:00
NHS England is to reconsider its decision not to fund a new preventative drug for HIV which it had claimed fell under councils’ public health responsibilities.
With a HSJ subscription you’ll unlock:
Already a subscriber? Sign into your account here
Part of HSJ Information Ltd. The White Chapel Building, 1st Floor, 10 Whitechapel High Street, London, E1 8QS. Registered in England and Wales. Company registration 2530185
Site powered by Webvision Cloud